News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Actinogen Medical.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Atomo sells more HIV Self-Tests; Actinogen begins Phase 2b trial on Alzheimer’s
Health & Biotech
The next Neuren? Nyrada chases after two big markets – stroke and traumatic brain injury
Health & Biotech
Diagnosing mental disorder through sleep: How TrivarX could capture this huge research market
Health & Biotech
Check Up: Aussie biotech Avarax on the verge of peanut allergy cure; and recent ASX health winners
Health & Biotech
ASX Health Winners January: ‘Invest in business not science’, as SHG and PAA top winners list
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it
News
In Case You Missed It: Visual spodumene and Covid clinical trials
Health & Biotech
ASX Health Stocks: Botanix Pharma plunges 25pc after FDA requests this minor change
Health & Biotech
Move over Neuren – Bioshares reckons these ASX health stocks could pop with upcoming key catalysts
Health & Biotech
ScoPo’s Powerplays: Mesoblast sinks Health sector, and how to live 24 years longer
News
Closing Bell: RBA pause positivity short lived as ASX 200 has worst day in four weeks
News
Top 10 at 10: AW1 makes big copper find in Canada; Breast cancer diagnostics test gets a lift
Health & Biotech
As dementia takes toll on Aussies, here’s why Alterity and these ASX biotechs are in the box seat
Health & Biotech
Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities?
Health & Biotech
Alzheimer’s drug no longer a moonshot as race heats up, ASX-listed Actinogen in the running
News
